UTAH MEDICAL PRODUCTS INC
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $2.7M | $2.6M | $2.6M | $2.6M | $3.0M | $3.0M | $2.9M | $3.6M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $210.0K | $211.0K | $212.0K | $209.0K | $205.0K | $200.0K | $200.0K | $203.0K |
| Amortization | $16.0K | $462.0K | $533.0K | $545.0K | $539.0K | $509.0K | $517.0K | $525.0K |
| Stock-Based Compensation | $72.0K | $120.0K | $111.0K | $94.0K | $86.0K | $82.0K | $72.0K | $53.0K |
| Net Cash from Operating Activities | $1.4M | $3.1M | $3.5M | $3.9M | $2.9M | $4.5M | $2.9M | $3.9M |
| Investing Activities | ||||||||
| Capital Expenditures | $134.0K | $130.0K | $109.0K | $27.0K | $51.0K | $184.0K | $9.0K | $89.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-134.0K | $-130.0K | $-109.0K | $-27.0K | $-51.0K | $-184.0K | $-9.0K | $-89.0K |
| Financing Activities | ||||||||
| Dividends Paid | $987.0K | $989.0K | $977.0K | $988.0K | $1.0M | $1.0M | $1.0M | $1.1M |
| Stock Repurchases | $78.0K | $128.0K | $994.0K | $653.0K | $3.5M | $3.2M | $6.7M | $3.9M |
| Net Cash from Financing Activities | $-1.1M | $-1.1M | $-2.0M | $-1.6M | $-4.5M | $-4.2M | $-7.7M | $-4.9M |
| Net Change in Cash | $122.0K | $1.7M | $1.5M | $2.1M | $-1.1M | $349.0K | $-5.5M | $-767.0K |
| Free Cash Flow | $1.2M | $3.0M | $3.4M | $3.9M | $2.8M | $4.3M | $2.9M | $3.8M |